Literature DB >> 10713149

Specificity of DNA lesion bypass by the yeast DNA polymerase eta.

F Yuan1, Y Zhang, D K Rajpal, X Wu, D Guo, M Wang, J S Taylor, Z Wang.   

Abstract

DNA polymerase eta (Pol(eta), xeroderma pigmentosum variant, or Rad30) plays an important role in an error-free response to unrepaired UV damage during replication. It faithfully synthesizes DNA opposite a thymine-thymine cis-syn-cyclobutane dimer. We have purified the yeast Pol(eta) and studied its lesion bypass activity in vitro with various types of DNA damage. The yeast Pol(eta) lacked a nuclease or a proofreading activity. It efficiently bypassed 8-oxoguanine, incorporating C, A, and G opposite the lesion with a relative efficiency of approximately 100:56:14, respectively. The yeast Pol(eta) efficiently incorporated a C opposite an acetylaminofluorene-modified G, and efficiently inserted a G or less frequently an A opposite an apurinic/apyrimidinic (AP) site but was unable to extend the DNA synthesis further in both cases. However, some continued DNA synthesis was observed in the presence of the yeast Pol(zeta) following the Pol(eta) action opposite an AP site, achieving true lesion bypass. In contrast, the yeast Pol(alpha) was able to bypass efficiently a template AP site, predominantly incorporating an A residue opposite the lesion. These results suggest that other than UV damage, Pol(eta) may also play a role in bypassing additional DNA lesions, some of which can be error-prone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713149     DOI: 10.1074/jbc.275.11.8233

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells.

Authors:  P Kannouche; B C Broughton; M Volker; F Hanaoka; L H Mullenders; A R Lehmann
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  The many faces of DNA polymerases: strategies for mutagenesis and for mutational avoidance.

Authors:  E C Friedberg; W J Feaver; V L Gerlach
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  High accuracy of DNA synthesis catalyzed by the complex of DNA polymerases of the alpha family in the presence of autonomous 3'-->5' exonucleases.

Authors:  I V Shevelev; N V Belyakova; T P Kravetskaya; E A Smirnova; V M Krutyakov
Journal:  Dokl Biochem Biophys       Date:  2001 May-Jun       Impact factor: 0.788

Review 4.  Managing DNA polymerases: coordinating DNA replication, DNA repair, and DNA recombination.

Authors:  M D Sutton; G C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

5.  Accessibility of DNA polymerases to repair synthesis during nucleotide excision repair in yeast cell-free extracts.

Authors:  X Wu; D Guo; F Yuan; Z Wang
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 6.  Somatic immunoglobulin hypermutation.

Authors:  Marilyn Diaz; Paolo Casali
Journal:  Curr Opin Immunol       Date:  2002-04       Impact factor: 7.486

Review 7.  Somatic hypermutation in human B cell subsets.

Authors:  N S Longo; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2001-12

8.  Difference between deoxyribose- and tetrahydrofuran-type abasic sites in the in vivo mutagenic responses in yeast.

Authors:  Chie Otsuka; Sachi Sanadai; Yasuhiro Hata; Hisanori Okuto; Vladimir N Noskov; David Loakes; Kazuo Negishi
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

9.  Error-prone lesion bypass by human DNA polymerase eta.

Authors:  Y Zhang; F Yuan; X Wu; O Rechkoblit; J S Taylor; N E Geacintov; Z Wang
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

10.  Enzymatic switching for efficient and accurate translesion DNA replication.

Authors:  Scott D McCulloch; Robert J Kokoska; Olga Chilkova; Carrie M Welch; Erik Johansson; Peter M J Burgers; Thomas A Kunkel
Journal:  Nucleic Acids Res       Date:  2004-08-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.